Advertisement

Perioperative Beta-Blockade: Myths and Realities

  • G. Howard-Alpe
  • P. Foëx
Conference paper

Abstract

In 1997, the American College of Physicians published a guideline for assessing and managing patients with coronary artery disease who undergo major noncardiac surgery [1]. An important recommendation was that all eligible patients should receive a beta-blocker (atenolol).

Keywords

Coronary Bypass Surgery Noncardiac Surgery Major Vascular Surgery Revise Cardiac Risk Index Major Noncardiac Surgery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Palda VA, Detsky AS (1997) Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 127:313–328PubMedGoogle Scholar
  2. 2.
    Mangano DT (1995) Preoperative risk assessment: many studies, few solutions. Is a cardiac risk assessment paradigm possible? Anesthesiology 83:897–901PubMedCrossRefGoogle Scholar
  3. 3.
    ISIS-1 (1986) Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2:57–66Google Scholar
  4. 4.
    Owen A (1998) Intravenous beta blockade in acute myocardial infarction. Should be used in combination with thrombolysis. Br Med J 317:226–227Google Scholar
  5. 5.
    NCEPOD (2001) Then and Now: The 2000 Report of the National Confidential Enquiry into Perioperative Deaths: The National Confidential Enquiry into Perioperative DeathsGoogle Scholar
  6. 6.
    NCEPOD (1999) Extremes of Age. The 1999 Report of the National Confidential Enquity into Perioperative Deaths: The National Confidential Enquiry into Perioperative DeathsGoogle Scholar
  7. 7.
    Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049PubMedGoogle Scholar
  8. 8.
    Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118:1134–1141PubMedCrossRefGoogle Scholar
  9. 9.
    Mangano DT (1998) Adverse outcomes after surgery in the year 2001 — a continuing odyssey. Anesthesiology 88:561–564PubMedCrossRefGoogle Scholar
  10. 10.
    Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789–1794PubMedCrossRefGoogle Scholar
  11. 11.
    Mamode N, Docherty G, Lowe GD et al (2001) The role of myocardial perfusion scanning, heart rate variability and D-dimers in predicting the risk of perioperative cardiac complications after peripheral vascular surgery. Eur J Vasc Endovasc Surg 22:499–508PubMedCrossRefGoogle Scholar
  12. 12.
    Mangano DT, Browner WS, Hollenberg M et al (1992) Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 268:233–239PubMedCrossRefGoogle Scholar
  13. 14.
    Eagle KA, Berger PB, Calkins H et al (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery — executive summary. J Am Coll Cardiol 39:542–553PubMedCrossRefGoogle Scholar
  14. 15.
    McFalls EO, Ward HB, Moritz TE et al (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl JMed 351:2795–2804CrossRefGoogle Scholar
  15. 16.
    Grayburn PA, Hillis LD (2003) Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Annals Int Med 138:506–511Google Scholar
  16. 17.
    Ohtsuka T, Hamada M, Hiasa G et al (2001) Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37:412–417PubMedCrossRefGoogle Scholar
  17. 18.
    Vallance P, Collier J, Bhagat K (1997) Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 349:1391–1392PubMedCrossRefGoogle Scholar
  18. 19.
    Pepine CJ, Cohn PF, Ellenbogen KA (1994) Advisory Group reports on silent myocardial ischemia, coronary atherogenesis, and cardiac emergencies. Council for Myocardial Ischemia and Infarction. Am J Cardiol 73:39B–44BPubMedCrossRefGoogle Scholar
  19. 20.
    Feringa HH, Bax JJ, Schouten O et al (2006) Beta-blockers improve in-hospital and long-term survival in patients with severe left ventricular dysfunction undergoing major vascular surgery. Eur J Vasc Endovasc Surg 31:351–358PubMedCrossRefGoogle Scholar
  20. 21.
    Carlberg B, Samuelsson O, Lindholm LH (2004) Atenolol in hypertension: is it a wise choice? Lancet 364:1684–1689PubMedCrossRefGoogle Scholar
  21. 23.
    NICE (2006) Hypertension: management of hypertension in adults in primary care, partial update of NICE clinical guideline 18. National Institute for Health and Clinical Excellence clinical guideline 34Google Scholar
  22. 24.
    Ayescue Q, Brown B, Fabian L et al (1972) The experts opine. Survey Anesthesiol 16:484–487Google Scholar
  23. 25.
    Prys-Roberts C, Foex P, Biro GP, Roberts JG (1973) Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 45:671–681PubMedCrossRefGoogle Scholar
  24. 26.
    Stone JG, Foex P, Sear JW et al (1988) Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 68:495–500PubMedGoogle Scholar
  25. 27.
    Wallace A, Layug B, Tateo I et al (1998) Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 88:7–17PubMedCrossRefGoogle Scholar
  26. 28.
    Pasternack PF, Imparato AM, Baumann FG et al (1987) The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 76:III1–7PubMedGoogle Scholar
  27. 29.
    Yeager RA, Moneta GL, Edwards JM et al (1995) Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. Arch Surg 130:869–872; discussion 872–873PubMedGoogle Scholar
  28. 30.
    Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720PubMedCrossRefGoogle Scholar
  29. 31.
    Poldermans D, Boersma E, Bax JJ et al (2001) Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 22:1353–1358PubMedCrossRefGoogle Scholar
  30. 32.
    Roizen MF (1988) Should we all have a sympathectomy at birth? Or at least preoperatively? Anesthesiology 68:482–484PubMedCrossRefGoogle Scholar
  31. 33.
    Devereaux PJ, Beattie WS, Choi PT et al (2005) How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and metaanalysis of randomised controlled trials. Br Med J 331:313–321CrossRefGoogle Scholar
  32. 34.
    Wiesbauer F, Schlager O, Domanovits H et al (2007) Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and metaanalysis. Anesth Analg 104:27–41PubMedCrossRefGoogle Scholar
  33. 35.
    Raby KE, Brull SJ, Timimi F et al (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477–482PubMedCrossRefGoogle Scholar
  34. 36.
    Feringa HH, Bax JJ, Boersma E et al (2006) High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114:1344–1139CrossRefGoogle Scholar
  35. 37.
    Auerbach AD, Goldman L (2002) Beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 287:1435–1444PubMedCrossRefGoogle Scholar
  36. 38.
    Stevens RD, Burri H, Tramer MR (2003) Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97:623–633PubMedCrossRefGoogle Scholar
  37. 39.
    Lindenauer PK, Pekow P, Wang K et al (2005) Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353:349–361PubMedCrossRefGoogle Scholar
  38. 40.
    Biccard BM, Sear JW, Foex P (2006) Acute peri-operative beta blockade in intermediate-risk patients. Anaesthesia 61:924–931PubMedCrossRefGoogle Scholar
  39. 41.
    Fleisher LA, Beckman JA, Brown KA et al (2006) ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. Circulation 113:2662–2674PubMedCrossRefGoogle Scholar
  40. 42.
    Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990PubMedCrossRefGoogle Scholar
  41. 43.
    Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized doubleblind controlled trial. J Vasc Surg 41:602–609PubMedCrossRefGoogle Scholar
  42. 44.
    Devereaux PJ, Yang H, Guyatt GH et al (2006) Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 152:223–230PubMedCrossRefGoogle Scholar
  43. 45.
    Shojania K, Duncan B, McDonald K (2001) Making health care safer: a critical analysis of patients safety practices. In: Quality AfHRa, ed. Rockville (Maryland)Google Scholar
  44. 46.
    London MJ (2007) Con: Beta-blockers are indicated for all adults at increased risk undergoing noncardiac surgery. Anesth Analg 104:11–14PubMedCrossRefGoogle Scholar
  45. 47.
    Fleisher LA (2007) Perioperative beta-blockade: how best to translate evidence into practice. Anesth Analg 104:1–3PubMedCrossRefGoogle Scholar
  46. 48.
    Hoeks SE, Scholte Op Reimer WJ, van Urk H et al (2007) Increase of l-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients. Eur J Vasc Endovasc Surg 33:13–19PubMedCrossRefGoogle Scholar
  47. 49.
    Lanfear DE, Jones PG, Marsh S et al (2005) Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 294:1526–1533PubMedCrossRefGoogle Scholar
  48. 50.
    Zaugg M, Bestmann L, Wacker J et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: a double-blinded, placebo-controlled, multicenter trial with l-year follow-up. Anesthesiology 107:33–44PubMedCrossRefGoogle Scholar
  49. 51.
    ten Broecke PW, De Hert SG, Mertens E, Adriaensen HF (2003) Effect of preoperative beta-blockade on perioperative mortality in coronary surgery. Br J Anaesth 90:27–31PubMedCrossRefGoogle Scholar
  50. 52.
    Sear JW, Howell SJ, Sear YM et al (2001) Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patients. Br J Anaesth 86:506–512PubMedCrossRefGoogle Scholar
  51. 53.
    Giles JW, Sear JW, Foex P (2004) Effect of chronic beta-blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies. Anaesthesia 59:574–583PubMedCrossRefGoogle Scholar
  52. 54.
    Yndgaard S, Lippert FK, Bertheisen PG (1997) Are patients chronically treated with beta 1-adrenoceptor antagonists in fact beta-blocked? J Cardiothor Vascular Anesth 11:32–36CrossRefGoogle Scholar
  53. 55.
    Tzivoni D, Medina A, David D et al (1998) Effect of metoprolol in reducing myocardial ischemic threshold during exercise and during daily activity. Am J Cardiol 81:775–777PubMedCrossRefGoogle Scholar
  54. 56.
    Stone JG, Foex P, Sear JW et al (1988) Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 61:675–679PubMedCrossRefGoogle Scholar
  55. 57.
    Gottlieb SS, Fisher ML, Kjekshus J et al (2002) Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation 105:1182–1188PubMedCrossRefGoogle Scholar
  56. 58.
    Kertai MD, Boersma E, Westerhout CM et al (2004) Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116:96–103PubMedCrossRefGoogle Scholar
  57. 59.
    Durazzo AE, Machado FS, Ikeoka DT et al (2004) Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39:967–975PubMedCrossRefGoogle Scholar
  58. 60.
    Lindenauer PK, Pekow P, Wang K et al (2004) Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 291:2092–2099PubMedCrossRefGoogle Scholar
  59. 61.
    O’Neil Callahan K, Katsimaglis G, Tepper MR et al (2005) Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45:336–342PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • G. Howard-Alpe
    • 1
  • P. Foëx
    • 1
  1. 1.Nuffield Department of AnaestheticsUniversity of OxfordUK

Personalised recommendations